Skip to main content

Multiple Sclerosis: Drugs

Volume 488: debated on Friday 27 February 2009

To ask the Secretary of State for Health what assessment his Department has made of the clinical effects of low doses of naltrexone for patients with multiple sclerosis; and if he will make a statement. (258834)

The Department has made no assessment of the clinical effectiveness of low dose naltrexone for those living with multiple sclerosis.